Ayurveda means Science of Life and it has been the traditional practice of medicine in India since 3500 BC. There are nearly 1500 herbal products in this system of medicine. Ayurvedic products did not gain much recognition in the western world until recently because these products have been made in the traditional way described in Ayurveda without any scientific standardization, safety studies and clinical evidence. Natreon, Inc. was founded by pharmaceutical scientists to bring Ayurveda to prominence in the world by using scientific approach.
Natreon, Inc. is a 16 year old company located in New Jersey with a state of the art R&D facility in Kolkata, India, and is focused on developing and marketing Ayurvedic products backed by extensive research, high degree of standardization, multiple clinical studies, safety studies, and intellectual property.
is headed by Prof. Shibnath Ghosal, a Fullbright scholar and an eminent natural product chemist with hundreds of publications in scientific journals and a group of Ph.D. and Masters’ level scientists. Natreon’s scientific research includes process optimization, development of chromatographic analytical methods such as HPLC, HPTLC, GC‐MS and LC‐MS for standardization, development of marker compounds, and pharmacological studies. Safety studies are done in USA and clinical studies are conducted in reputed institutes in India as well as USA.
is a super antioxidant (ORACFN of 47,000 µmoles TE/g) and an excellent cardiovascular product, which is all natural, derived from the edible fruits of Phyllanthus emblica, organic and non‐GMO. Unlike CoQ10 and fish oils, Capros® is completely water soluble and stable making it suitable for both solid dosage forms as well as hot and cold beverages. The claims are backed by eight human clinical studies in type 2 diabetics, healthy volunteers and in pre‐metabolic syndrome subjects, including one at Ohio State University Medical Center. Four studies have been published so far and another was accepted for publication. An ischemia reperfusion study and mechanism of action studies were conducted at University of Connecticut, which showed that Capros® may help mitigate the effects of ischemia through GSK3β‐β Catenin pathway. This study will be submitted soon for publication in International Journal of Cardiology. Capros® recently received a no objection GRAS letter from FDA. A summary of its actions, compared to fish and krill oils, is given below:
is the best‐selling Ashwagandha in the market with anti‐stress, anti‐ hyperlipidemic, cognition enhancing and anti‐inflammatory properties. It is derived from a unique blend of the leaves and roots of Withania somnifera and is available as organic and non‐GMO. Sensoril® has been in the U.S. market for more than ten years with proven efficacy and safety. It is supported by seven clinical studies in type 2 diabetics and healthy volunteers, in addition to a cognition study in bipolar subjects at University of Pittsburgh, which was published in the Journal of Clinical Psychiatry. One anti‐ stress study with three different doses was published in J. of American Nutraceutical Association. Another study on the anti‐inflammatory properties of this product at University of Pittsburgh and an osteoarthritis study is in progress at NIMS, Hyderabad, India.
is a Chromium III‐polyphenolic complex, which is a safer form of Chromium. It comes as a fine powder with a 2% concentration of Chromium which results in greater content uniformity in the finished capsules or tablets. One published clinical study with Crominex®‐3+ in adjuvant therapy with prescription oral anti‐diabetic drugs in type 2 diabetics has shown that it can reduce blood glucose levels, especially post‐prandial. Two additional human clinical studies – one in type 2 diabetics and the other in subjects with metabolic syndrome symptoms – have shown that Crominex®‐ 3+ improves endothelial function as well as cardiovascular health. A study in arthritic dogs at Murray State University in Kentucky has shown that Crominex‐3+ has significantly improved arthritic conditions in dogs. Additional clinical studies comparing Crominex® 3+ to other branded chromium products, such as Chromax®, Chromemate® and Zychrome®, are about to be completed.
is the latest introduction to Natreon’s product portfolio. It is a clinically proven, water‐ soluble, vegetarian, organic, non‐GMO product for joint health. It is derived from the edible fruits of Terminalia chebula with high concentrations of chebulinic acid and chebulagic acid. It decreases WOMAC & VAS scores and knee swelling index significantly in moderately osteoarthritic subjects. It also increases pain threshold force and pain tolerance force in healthy volunteers. In addition to joint health benefits, AyuFlex® is a super antioxidant with ORACFN value of 36,000 μmoles TE/g and helps improve the endothelial function and lipid profile. It has also shown to decrease the inflammatory biomarker hsCRP and glycosylated hemoglobin.
contains a minimum of 60% of Fulvic Acid and equivalents, derived from Shilajit and is a mitochondrial energy booster. It contains several amino acids and 40+ minerals, many of them trace minerals, required by our bodies for proper physiological functioning.
Patents & Trademarks:
Natreon has 19 U.S. and foreign patents and several registered trademarks in various countries.